ALNY Announces Partnership with Roche to Co-Develop and Co-Commercialize Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension. Alnylam to receive $310M upfront

$罗氏控股(RHHBY)$ $阿里拉姆制药(ALNY)$